These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15208511)

  • 21. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders.
    Tanaka M; Naruo T; Nagai N; Kuroki N; Shiiya T; Nakazato M; Matsukura S; Nozoe S
    J Psychiatr Res; 2003; 37(1):17-22. PubMed ID: 12482466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The psychobiology of eating behavior in anorexia nervosa.
    Halmi KA
    Psychiatry Res; 1996 Apr; 62(1):23-9. PubMed ID: 8739112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal disturbances in anorexia nervosa and bulimia nervosa.
    Hadley SJ; Walsh BT
    Curr Drug Targets CNS Neurol Disord; 2003 Feb; 2(1):1-9. PubMed ID: 12769807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa.
    Keel PK; Wolfe BE; Liddle RA; De Young KP; Jimerson DC
    Arch Gen Psychiatry; 2007 Sep; 64(9):1058-66. PubMed ID: 17768271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a unified theory of serotonin dysregulation in eating and related disorders.
    Brewerton TD
    Psychoneuroendocrinology; 1995; 20(6):561-90. PubMed ID: 8584599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa.
    Galusca B; Jeandel L; Germain N; Alexandre D; Leprince J; Anouar Y; Estour B; Chartrel N
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2012-8. PubMed ID: 22466335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic dysfunction across the eating disorders: relationship to eating behaviour, purging behaviour, nutritional status and general psychopathology.
    Monteleone P; Brambilla F; Bortolotti F; Maj M
    Psychol Med; 2000 Sep; 30(5):1099-110. PubMed ID: 12027046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine dysregulation of food intake in eating disorders.
    Monteleone P; Castaldo E; Maj M
    Regul Pept; 2008 Aug; 149(1-3):39-50. PubMed ID: 18582958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, psychopathological and personality correlates of interoceptive awareness in anorexia nervosa, bulimia nervosa and obesity.
    Fassino S; Pierò A; Gramaglia C; Abbate-Daga G
    Psychopathology; 2004; 37(4):168-74. PubMed ID: 15237246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders.
    Smitka K; Prochazkova P; Roubalova R; Dvorak J; Papezova H; Hill M; Pokorny J; Kittnar O; Bilej M; Tlaskalova-Hogenova H
    Front Endocrinol (Lausanne); 2021; 12():613983. PubMed ID: 33953692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychobiological aspects of anorexia nervosa].
    Herpertz S; Schweiger U
    Z Psychosom Med Psychother; 2001; 47(2):179-204. PubMed ID: 11593461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimaging in eating disorders.
    Stamatakis EA; Hetherington MM
    Nutr Neurosci; 2003 Dec; 6(6):325-34. PubMed ID: 14744036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common biological pathways in eating disorders and obesity.
    Ericsson M; Poston WS; Foreyt JP
    Addict Behav; 1996; 21(6):733-43. PubMed ID: 8904939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.
    Kaye W; Gendall K; Strober M
    Biol Psychiatry; 1998 Nov; 44(9):825-38. PubMed ID: 9807638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin functioning in eating disorders.
    Monteleone P; DiLieto A; Castaldo E; Maj M
    CNS Spectr; 2004 Jul; 9(7):523-9. PubMed ID: 15208512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide abnormalities in anorexia nervosa.
    Kaye WH
    Psychiatry Res; 1996 Apr; 62(1):65-74. PubMed ID: 8739116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.
    Brambilla F
    CNS Drugs; 2001; 15(2):119-36. PubMed ID: 11460890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A ghrelin gene variant may predict crossover rate from restricting-type anorexia nervosa to other phenotypes of eating disorders: a retrospective survival analysis.
    Ando T; Komaki G; Nishimura H; Naruo T; Okabe K; Kawai K; Takii M; Oka T; Kodama N; Nakamoto C; Ishikawa T; Suzuki-Hotta M; Minatozaki K; Yamaguchi C; Nishizono-Maher A; Kono M; Kajiwara S; Suematsu H; Tomita Y; Ebana S; Okamoto Y; Nagata K; Nakai Y; Koide M; Kobayashi N; Kurokawa N; Nagata T; Kiriike N; Takenaka Y; Nagamine K; Ookuma K; Murata S;
    Psychiatr Genet; 2010 Aug; 20(4):153-9. PubMed ID: 20421852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic digoxin, hemispheric chemical dominance, and eating behavior.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Aug; 113(8):1127-41. PubMed ID: 12888426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro- and macroanalyses of patterns within a meal in anorexia and bulimia nervosa.
    Sunday SR; Halmi KA
    Appetite; 1996 Feb; 26(1):21-36. PubMed ID: 8660030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.